We are live on ! Find out more
GNBT

GENEREX BIOTECHNOLOGY CORP
GNBT

Delisted

GNBT was delisted on the 20th of October, 2010.

Back to rankings

1 hedge funds and large institutions have $1.02K invested in GENEREX BIOTECHNOLOGY CORP in 2014 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

23% less capital invested

Capital invested by funds: $1.33K → $1.02K (-$304)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Janney Montgomery Scott
1
Janney Montgomery Scott
Pennsylvania
$1.02K – – –

GNBT Hedge Fund Activity: Q3 2014 in Review

1 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in GENEREX BIOTECHNOLOGY CORP (GNBT) for Q3 2014, worth a combined $1.02K — down 23% from $1.33K a quarter earlier.

Fund positioning in GNBT was balanced in Q3 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held GENEREX BIOTECHNOLOGY CORP (GNBT) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $1.02K of GENEREX BIOTECHNOLOGY CORP stock for Q3 2014, down 23% quarter-over-quarter.
  • 0 funds opened new GENEREX BIOTECHNOLOGY CORP positions in Q3 2014 and 0 closed out.

Based on aggregated 13F filings for Q3 2014.